Posted by admin on May 13th, 2022

Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) – Telsey Advisory Group issued their Q3 2024 earnings estimates for Bath & Body Works in a research note issued to investors on Thursday, May 12th. Telsey Advisory Group analyst D. Telsey anticipates that the company will earn $1.09 per share for the quarter. Telsey Advisory Group has a “Outperform” rating and a $70.00 price target on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2024 earnings at $2.96 EPS.

Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings results on Wednesday, February 23rd. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. The firm had revenue of $3.03 billion for the quarter, compared to analysts’ expectations of $2.96 billion. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. The company’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.96 EPS.

Several other research firms have also recently weighed in on BBWI. MKM Partners lowered their price target on Bath & Body Works from $94.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, February 24th. JPMorgan Chase & Co. decreased their target price on Bath & Body Works from $105.00 to $81.00 and set an “overweight” rating on the stock in a report on Thursday, February 24th. Zacks Investment Research cut Bath & Body Works from a “buy” rating to a “hold” rating in a report on Monday. Wells Fargo & Company decreased their target price on Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating on the stock in a report on Tuesday, April 5th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Bath & Body Works from $86.00 to $78.00 and set a “buy” rating on the stock in a report on Thursday, February 24th. Three investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Bath & Body Works currently has an average rating of “Buy” and an average target price of $78.63.

Shares of NYSE BBWI traded up $2.27 during midday trading on Friday, hitting $50.81. 17,688 shares of the stock traded hands, compared to its average volume of 4,118,245. The firm has a 50-day moving average of $50.26 and a two-hundred day moving average of $60.00. The firm has a market capitalization of $12.12 billion, a P/E ratio of 9.87, a PEG ratio of 1.17 and a beta of 1.56. Bath & Body Works has a one year low of $44.17 and a one year high of $82.00.

In other news, CFO Wendy C. Arlin sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total transaction of $330,000.00. Following the completion of the transaction, the chief financial officer now owns 98,888 shares in the company, valued at $5,438,840. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.37% of the company’s stock.

Several institutional investors have recently modified their holdings of BBWI. Acadian Asset Management LLC purchased a new position in Bath & Body Works in the fourth quarter worth about $30,000. Northwestern Mutual Wealth Management Co. grew its position in Bath & Body Works by 119.7% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 525 shares of the company’s stock worth $26,000 after acquiring an additional 286 shares in the last quarter. Prospera Financial Services Inc purchased a new position in Bath & Body Works in the first quarter worth about $25,000. CX Institutional purchased a new position in Bath & Body Works in the third quarter worth about $34,000. Finally, Alpha Paradigm Partners LLC purchased a new position in Bath & Body Works in the fourth quarter worth about $40,000. Hedge funds and other institutional investors own 97.11% of the company’s stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.

FY2023 EPS Estimates for High Liner Foods Inc Raised by Analyst (TSE:HLF)

Zacks Investment Research Lowers Udemy (NASDAQ:UDMY) to Hold